In collaboration with Consulting Editor, Dr. Norman Gitlin, Guest Editor Dr. Catherine Frenette has assembled expert authors to provide current updates on Hepatocellular Carcinoma (HCC). This issue asks important questions and provides answers and current thoughts on the staging and treatment of HCC. Clinical review articles are specifically dedicated to the following topics: The Changing Global Epidemiology of Hepatocellular Carcinoma; Prevention Strategies for HCC; Biomarkers or Biopsy for Diagnosis of HCC; Screening and Surveillance Strategies to Improve the Chance of Success; Imaging Diagnosis of HCC; Surgical Resection: Old dog--Any new tricks; Hepatocellular Carcinoma and Liver Transplant: How Will Organ Allocation Changes Affect the HCC Patient Within Transplant Criteria; Downstaging to Liver Transplant: Success Involves Choosing the Right Patient; Locoregional Therapies for Hepatocellular Carcinoma: What has Changed in the Past Ten Years; External Beam Radiotherapy: Is There a Place for This in HCC Treatment; Tyrosine Kinase Inhibitors and Hepatocellular Carcinoma; Immuno-oncology for Hepatocellular Carcinoma: The Present and the Future; Management of Side Effects of Systemic Therapies for HCC: Guide for the Hepatologist; and Why a Multi-disciplinary Tumor Board is Critical for Success with Hepatocellular Carcinoma. Readers will come away with the information they need to improve patient outcomes in the patient with HCC.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xii 7. Preface - p. xiii 8. The Changing Global Epidemiology of Hepatocellular Carcinoma - p. 535 9. Lifestyle and Environmental Approaches for the Primary Prevention of Hepatocellular Carcinoma - p. 549 10. Role of Biomarkers and Biopsy in Hepatocellular Carcinoma - p. 577 11. Hepatocellular Carcinoma: Role of Pathology in the Era of Precision Medicine - p. 591 12. Surveillance for Hepatocellular Carcinoma - p. 611 13. Imaging Diagnosis of Hepatocellular Carcinoma: The Liver Imaging Reporting and Data System, Why and How? - p. 623 14. Surgical Resection: Old Dog, Any New Tricks? - p. 637 15. The Impact of Allocation Changes on Patients with Hepatocellular Carcinoma - p. 657 16. Downstaging to Liver Transplant: Success Involves Choosing the Right Patient - p. 665 17. Locoregional Therapies for Hepatocellular Carcinoma: What Has Changed in the Past Ten Years? - p. 681 18. Role of External Beam Radiotherapy in Hepatocellular Carcinoma - p. 701 19. Tyrosine Kinase Inhibitors and Hepatocellular Carcinoma - p. 719 20. Immuno-oncology for Hepatocellular Carcinoma: The Present and the Future - p. 739 21. Management of Side Effects of Systemic Therapies for Hepatocellular Carcinoma: Guide for the Hepatologist - p. 755 22. Multidisciplinary Team Management of Hepatocellular Carcinoma Is Standard of Care - p. 771
In collaboration with Consulting Editor, Dr. Norman Gitlin, Guest Editor Dr. Catherine Frenette has assembled expert authors to provide current updates on Hepatocellular Carcinoma (HCC). This issue asks important questions and provides answers and current thoughts on the staging and treatment of HCC. Clinical review articles are specifically dedicated to the following topics: The Changing Global Epidemiology of Hepatocellular Carcinoma; Prevention Strategies for HCC; Biomarkers or Biopsy for Diagnosis of HCC; Screening and Surveillance Strategies to Improve the Chance of Success; Imaging Diagnosis of HCC; Surgical Resection: Old dog--Any new tricks; Hepatocellular Carcinoma and Liver Transplant: How Will Organ Allocation Changes Affect the HCC Patient Within Transplant Criteria; Downstaging to Liver Transplant: Success Involves Choosing the Right Patient; Locoregional Therapies for Hepatocellular Carcinoma: What has Changed in the Past Ten Years; External Beam Radiotherapy: Is There a Place for This in HCC Treatment; Tyrosine Kinase Inhibitors and Hepatocellular Carcinoma; Immuno-oncology for Hepatocellular Carcinoma: The Present and the Future; Management of Side Effects of Systemic Therapies for HCC: Guide for the Hepatologist; and Why a Multi-disciplinary Tumor Board is Critical for Success with Hepatocellular Carcinoma. Readers will come away with the information they need to improve patient outcomes in the patient with HCC.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xii 7. Preface - p. xiii 8. The Changing Global Epidemiology of Hepatocellular Carcinoma - p. 535 9. Lifestyle and Environmental Approaches for the Primary Prevention of Hepatocellular Carcinoma - p. 549 10. Role of Biomarkers and Biopsy in Hepatocellular Carcinoma - p. 577 11. Hepatocellular Carcinoma: Role of Pathology in the Era of Precision Medicine - p. 591 12. Surveillance for Hepatocellular Carcinoma - p. 611 13. Imaging Diagnosis of Hepatocellular Carcinoma: The Liver Imaging Reporting and Data System, Why and How? - p. 623 14. Surgical Resection: Old Dog, Any New Tricks? - p. 637 15. The Impact of Allocation Changes on Patients with Hepatocellular Carcinoma - p. 657 16. Downstaging to Liver Transplant: Success Involves Choosing the Right Patient - p. 665 17. Locoregional Therapies for Hepatocellular Carcinoma: What Has Changed in the Past Ten Years? - p. 681 18. Role of External Beam Radiotherapy in Hepatocellular Carcinoma - p. 701 19. Tyrosine Kinase Inhibitors and Hepatocellular Carcinoma - p. 719 20. Immuno-oncology for Hepatocellular Carcinoma: The Present and the Future - p. 739 21. Management of Side Effects of Systemic Therapies for Hepatocellular Carcinoma: Guide for the Hepatologist - p. 755 22. Multidisciplinary Team Management of Hepatocellular Carcinoma Is Standard of Care - p. 771
